A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Sanofi
Barbara Ann Karmanos Cancer Institute
Checkpoint Therapeutics, Inc.
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)
Montefiore Medical Center
AbbVie
AbbVie
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
University of Arizona
Amgen
Stanford University
Boehringer Ingelheim
University of Kentucky